Skip to main content

Table 2 Data relating to ECMO treatment

From: Extracorporeal membrane oxygenation for severe COVID-19-associated acute respiratory distress syndrome in Poland: a multicenter cohort study

Group of variables

Variable

All (n = 158)

Death (n = 117)

Survival (n = 41)

p

ECMO treatment

VV ECMO

156 (98.7%)

115 (98.3%)

41 (100.0%)

0.975

Extubation on ECMO

7 (4.4%)

2 (1.7%)

5 (12.2%)

0.018

Tracheostomy on ECMO

79 (50.0%)

58 (49.6%)

21 (51.2%)

1.000

ECMO complications

Hemorrhagic

88 (55.7%)

68 (58.1%)

20 (48.8%)

0.394

Neurological

16 (10.1%)

12 (10.3%)

4 (9.8%)

0.834

Renal

59 (37.3%)

51 (43.6%)

8 (19.5%)

0.011

Cardiovascular

47 (29.7%)

38 (32.5%)

9 (22.0%)

0.284

Pulmonary

28 (17.7%)

24 (20.5%)

4 (9.8%)

0.189

Metabolic

22 (13.9%)

18 (15.4%)

4 (9.8%)

0.526

Limb ischemia

3 (1.9%)

3 (2.6%)

0 (0.0%)

0.711

Infection

125 (79.1%)

93 (79.5%)

32 (78.0%)

0.977

  1. Bold indicates significant (p < 0.05)